XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value of Financial Instruments
9 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

4.   Fair Value of Financial Instruments

The Company’s financial instruments generally include cash and cash equivalents, short-term investments, foreign currency forward contracts, trade and other receivables and accounts payable.  Due to the short-term maturities of cash and cash equivalents, trade and other receivables and accounts payable, the carrying amounts of these financial instruments are deemed to approximate their fair value on the respective balance sheet dates.  The valuation technique used to measure the fair value of the contingent consideration was derived from models utilizing market observable inputs.  

The Company measures short-term investments and derivatives at fair value on a recurring basis.

The following tables present the fair value of the Company’s contingent consideration and foreign currency forward contracts by valuation hierarchy and input (in thousands):

 

 

 

As of June 30, 2020

 

 

 

Quoted Prices in

Active Markets for

Identical Assets

(Level 1)

 

 

Significant

Other

Observable

(Level 2)

 

 

Significant

Unobservable

(Level 3)

 

 

Totals

 

Contingent Consideration

 

$

 

 

$

 

 

$

(11,574

)

 

$

(11,574

)

Foreign Currency Forward Contract

 

 

 

 

 

(13

)

 

 

 

 

 

(13

)

Total

 

$

 

 

$

(13

)

 

$

(11,574

)

 

$

(11,587

)

 

 

 

As of September 30, 2019

 

 

 

Quoted Prices in

Active Markets for

Identical Assets

(Level 1)

 

 

Significant

Other

Observable

(Level 2)

 

 

Significant

Unobservable

(Level 3)

 

 

Totals

 

Contingent Consideration

 

$

 

 

$

 

 

$

(9,940

)

 

$

(9,940

)

Foreign Currency Forward Contract

 

 

 

 

 

(4

)

 

 

 

 

$

(4

)

Total

 

$

 

 

$

(4

)

 

$

(9,940

)

 

$

(9,944

)

 

Assets and liabilities measured on a nonrecurring basis

The measurements utilized to determine the implied fair value of the Company’s contingent consideration as of June 30, 2020 represented significant unobservable inputs (Level 3).

 

The following table summarizes changes in the fair value of the Company’s Level 3 financial instruments for the nine months ended June 30, 2020:

 

Balance at October 1, 2019

$

9,940

 

Fair value adjustments

 

 

Balance at December 31, 2019

 

9,940

 

Fair value adjustments

 

972

 

Balance at March 31, 2020

 

10,912

 

Fair value adjustments

 

662

 

Balance at June 30, 2020

$

11,574

 

 

Adjustments to the fair value of the contingent consideration are based on Monte Carlo simulations utilizing inputs which include market comparable information and management assessments regarding potential future scenarios.  The Company believes its estimates and assumptions are reasonable, however, there is significant judgement involved.